We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03368664
Brief Title: A Study to Evaluate Efficacy, Safety, and Tolerability of Alemtuzumab in Pediatric Patients With RRMS With Disease Activity on Prior DMT (LemKids)

First Submitted : November 2, 2017
First Submitted that Met QC Criteria : December 5, 2017
First Posted : December 11, 2017

Results First Submitted : May 3, 2022
Results First Posted with QC Comments : May 27, 2022
Results First Submitted that Met QC Criteria : June 16, 2022
Results First Posted : July 12, 2022

Last Update Submitted that Met QC Criteria : June 16, 2022
Last Update Posted : July 12, 2022